Revolution Medicines (RVMD) Amortization of Deferred Charges (2020 - 2026)
Revolution Medicines (RVMD) recorded quarterly Amortization of Deferred Charges of $12.2 million in Q1 2026, up 2.18% quarter-over-quarter from $11.9 million in Q4 2025.
Revolution Medicines (RVMD) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends
Revolution Medicines' Amortization of Deferred Charges history runs 4 years deep, the most recent figure standing at $12.2 million for Q1 2026.
- In Q1 2026, Amortization of Deferred Charges changed N/A year-over-year to $12.2 million; the TTM figure through Mar 2026 stood at $36.4 million (up 3620.94% YoY), while the FY2025 annual figure was $24.2 million, changed N/A from the prior year.
- Amortization of Deferred Charges was $12.2 million for Q1 2026 at Revolution Medicines, up from $11.9 million in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $12.2 million in Q1 2026 to a low of $866000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Revolution Medicines | 32.33 Bn | 32.33 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.20 Mn |
| Mar 31, 2026 | 12.20 Mn |
| Dec 31, 2025 | 11.94 Mn |
| Dec 31, 2025 | 11.94 Mn |
| Sep 30, 2025 | 11.43 Mn |
| Sep 30, 2025 | 11.43 Mn |
| Jun 30, 2025 | 866,000.00 |
| Jun 30, 2025 | 866,000.00 |
| Dec 31, 2021 | 979,000.00 |
| Dec 31, 2021 | 979,000.00 |
| Sep 30, 2021 | 691,000.00 |
| Sep 30, 2021 | 691,000.00 |
| Jun 30, 2021 | 770,000.00 |
| Jun 30, 2021 | 770,000.00 |
| Mar 31, 2021 | 740,000.00 |
| Mar 31, 2021 | 740,000.00 |
| Dec 31, 2020 | 759,000.00 |
| Dec 31, 2020 | 759,000.00 |
| Sep 30, 2020 | 698,000.00 |
| Sep 30, 2020 | 698,000.00 |